Although a little unclear, some evidence suggests that Melanotan I also targets the MC-3R
At present, bariatric surgery (BS) is considered the benchmark treatment of morbid obesity, with well-established indications providing effective long-term outcomes [2, 3] that lead to sustained weight loss [4] and improvement in most weight-related comorbidities [5,6,7], with relatively low morbidity and mortality [8,9,10]
This hands-on instruction is invaluable and typically includes demonstration of how to attach a new needle, select the correct dose, perform the injection, and safely dispose of used needles in a sharps container
But those benefits are tied to ongoing treatment
So, GLP-1 agonists, or GLP-1 receptor agonists or analogs, are the medications that replicate the activity of the GLP-1 hormone